Talk:Sofosbuvir/velpatasvir/voxilaprevir
Latest comment: 3 years ago by Klbrain in topic Merge proposal
This is the talk page for discussing improvements to the Sofosbuvir/velpatasvir/voxilaprevir article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Sofosbuvir/velpatasvir/voxilaprevir.
|
Merge proposal
editMoving the stub, Voxilaprevir, to here seems very reasonable. Best to consolidate closely-related material in one place. Klbrain (talk) 15:37, 10 February 2021 (UTC)
- I find it awkward to have two or more drugboxes in one article. Also, I think it would be irritating to discuss one of the three components together with the combination, while the other two have their own articles. --ἀνυπόδητος (talk) 13:38, 18 February 2021 (UTC)
- OK, closing with no merge given the uncontested objection. Klbrain (talk) 06:48, 27 July 2021 (UTC)